The evolution of KTP laser vaporization of the prostate

Yonsei Medical Journal

Volumn 49, Issue 2, 2008, Pages 189-199

  Sountoulides, Petros ^a,b   Tsakiris, Peter ^a  

^a METROPOLITAN HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Benign prostatic hyperplasia; Lasers; Surgery

Indexed keywords

HEALTH CARE COST; HUMAN; LASER; LASER SURGERY; LOWER URINARY TRACT SYMPTOM; MINIMALLY INVASIVE SURGERY; POTASSIUM TITANYL PHOSPHATE LASER; PROSTATE HYPERTROPHY; REVIEW; TRANSURETHRAL RESECTION; VAPORIZATION;

HUMANS; LASER THERAPY; MALE; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 44649151897     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.2.189     Document Type: Review

References (60)

1. Rassweiler J, Schulze M, Stock C, Teber D, De La Rosette J. Bipolar transurethral resection of the prostate-technical modifications and early clinical experience. Minim Invasive Ther Allied Technol 2007;16:11-21.
2. Yoon CJ, Kim JY, Moon KH, Jung HC, Park TC. Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome. Yonsei Med J 2006;47:715-20.
3. Park DS, Cho TW, Lee YK, Lee YT, Hong YK, Jang WK. Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei Med J 2006;47:706-14.
4. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004;14:21-5.
5. Lee R, Gonzalez RR, Te AE. The evolution of photo-selective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 2006;24:405-9.
6. Te AE. The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol 2006;8 (Suppl 3):S24-30.
7. Rajbabu K, Dudderidge T, Barber N, Walsh K, Muir G. Evaluation of ideal irrigation fluid in 'Greenlight' photoselective vapourization of the prostate. Prostate Cancer Prostatic Dis 2007;10:101-3.
8. Barber NJ, Zhu G, Donohue JF, Thompson PM, Walsh K, Muir GH. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 2006;67:80-3.
9. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997;49:703-8.
10. Costello AJ, Johnson DE, Bolton DM. Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med 1992;12:121-4.
11. Hoffman RK MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003;169:210-5.
12. Watson G. Contact laser prostatectomy. World J Urol 1995;13:115-8.
13. Miki T, Kojima Y, Nonomura N, Matsumiya K, Kokado Y, Yoshioka T, et al. Transurethral visual laser ablation of the prostate for benign prostatic hyperplasia using a KTP/YAG laser. Int J Urol 1997;4:576-9.
14. Shingleton WB, Terrell F, Renfroe L, Kolski J, Fowler JE Jr. Low-power v high-power KTP laser: improved method of laser ablation of prostate. J Endourol 1999, 13:49-52.
15. Kollmorgen TA, Malek RS, Barrett D. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology 1996;48:217-22.
16. Langley SE, Gallegos CR, Moisey CU. A prospective randomized trial evaluating endoscopic Nd:YAG laser prostate ablation with or without potassium titanyl phosphate (KTP) laser bladder neck incision. Br J Urol 1997;80:880-4.
17. Carter A, Sells H, Speakman M, Ewings P, MacDonegh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999; 83:254-9.
18. Pearcy RM, Carter A, Sells H, O'Boyle P. Hybrid KTP/Nd: YAG laser treatment of the prostate versus TURP: 18 months' follow-up data. BJU Int 1999;83 (Suppl 4): 37.
19. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002;60:305-8.
20. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996;48:575-83.
21. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KIP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998;51: 254-6.
22. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163:1730-3.
23. Carter A, Sells H, O'Boyle PJ. High-power KTP laser for the treatment of symptomatic benign prostatic enlargement. BJU Int 1999;83:857-8.
24. Rajbabu K, Murr GH. GreenLight photoselective vaporization of prostate - a technical review. Prostate Cancer Prostatic Dis 2007;10 Suppl 1:S6-9.
25. Haley R, Boddy J, Wharton I, Sami T, Ryan P, Devarajan R. A retrospective audit of TURP to assess the potential impact of Green Light Laser surgery on the diagnosis of prostate cancer [abstract]. Eur Urol Suppl 2007;6:195.
26. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Müller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005;47:798-804.
27. Sarica K, Alkan E, Lüleci H, Taşci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005;19: 1199-202.
28. Kaplan SA. Expanding the role of photoselective vaporization of the prostate. Rev Urol 2006;8 Suppl 3:S3-8.
29. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-6.
30. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-8.
31. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004;18:976-81.
32. Dincel C, Samli M, Guler C, Demirbas M, Karalar M. Plasma kinetic vaporization of the prostate: clinical evaluation of a new technique. J Endourol 2004;18:293-8.
33. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photo-selective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006;97:1229-33.
34. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K. et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 2005;48:608-13.
35. Malek R, Kuntzman R, Barrett DM, Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174:1344-8.
36. Bachmann A, Ruszat R. The KTP-(greenlight-) laser-principles and experiences. Minim Invasive Ther Allied Technol 2007;16:5-10.
37. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH, Eur Urol 2006;49:970-8, discussion 978.
38. Ruszat R, Wyler S, Forster T, Sulser T, Bachmann A. Complications of photoselective vaporization of the prostate [abstract]. Eur Urol Suppl 2007;6:136.
39. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60.
40. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006;8: 367-71.
41. Parr NJ, Loh CS, Desmond AD. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 1989;64:623-5.
42. Dotan ZA, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, et al. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 2002;168:610-3, discussion 614.
43. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51:1031-8, discussion 1038-41.
44. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9.
45. Sandhu JS, Te AE. Photoselective vaporization of the prostate: the vaporization incision technique for large volume prostates [abstract]. J Urol 200,5;173 (4 Suppl): 366.
46. Ruszat R, Wyler S, Seifert HH, Reich O, Forster T, Sulser T, et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol 2006;50:1040-9.
47. Hirst G, Edwards M, James W, Bose P. Comparison of TURP and photoselective vaporization of the prostate (PVP) in men presenting with painful acute urinary retention [abstract]. Eur Urol Suppl 2007;6:192.
48. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005:48:965-71, discussion 972.
49. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello A. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5.
50. Bouchier-Hayes DM. Photoselective vaporization of the prostate-towards a new standard. Prostate Cancer Prostatic Dis 2007;10 Suppl 1:S104.
51. Ruszat R, Lehmann K, Wyler S, Forster T, Schurch L, Straumann U, et al. 24 months results of a prospective Bi-Center study of photoselective vaporization of the prostate (PVP) versus transurethral resection of the prostate (TURP) [abstract]. Eur Urol Suppl 2007;6:192.
52. de la Rosette J, Alivizatos G. Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities? Eur Urol 2006;50: 418-20.
53. Taub DA, Wei JT. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep 2006;7:272-81.
54. Chirikos TN, Sanford E. Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. J Urol 1996;155:1311-6.
55. de la Rosette J, Kortmann BB, Rossi C, Sonke GS, Floratos DL, Kiemeney LA. Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002;167;1734-9.
56. DiSantostefano RL, Biddle AK, Lavelle JJ. The long-term cost effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics 2006;24:171-91.
57. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso JV, Manzarbeitia F, Sarasa-Corral JL, Granizo JJ. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int 2005;96:1045-8.
58. Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006; 176:1500-6.
59. Alivizatos G, Skolarikos A. Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment. Prostate Cancer Prostatic Dis,2007;10:S15-20.
60. Te AE. Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2007;10:S2-5.